The current protocols include the bone scintigraphy and choline PET/CT to localize recurrence in patients having elevated serum PSA after treatment for prostate cancer.
Both methods show good agreement in the diagnosis of bone metastases, however conflicting results can be found. We present three cases in which a PET/CT was performed with 18F-Fluoride due to disagreement between the bone scintigraphy and 11C-Choline PET/CT. The 18F-Fluoride PET/CT was capable of confirming the existence of bone metastasis in all of them, so it may be an alternative to the MRI as a tracer of second bone imaging modality, although its use is limited by cost and availability.
Written by:
García JR, Riera E, Valls E, Soler M, Moragas M, Lomeña F. Are you the author?
Unidad PET/TC, CETIR-ERESA, Esplugues de Llobregat, Barcelona, España.
Reference: Rev Esp Med Nucl Imagen Mol. 2012 Jul 24. Epub ahead of print.
PubMed Abstract
PMID: 22835661
Article in Spanish.
UroToday.com Prostate Cancer Section
